Clinical Trials Browser

Phase 1 × Leukemia, Biphenotypic, Acute × plerixafor × Clear all

NCT01319864 2018-09-07

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute